10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
ELEVANCE HEALTH, INC. | |||
Ticker: ELV Fiscal Year: 2009 | |||
Statement Of Income Insurance Based Revenue | |||
Period Ending Dec 31, 2009 10-K (Filed: Feb 18, 2010) | |||
| (In Thousands, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2009 | Dec 31, 2008 | Dec 31, 2007 | |
| Revenues | |||
| Premiums | $ 56,382,000 | 57,101,000 | 55,865,000 |
| Administrative fees | 3,840,300 | 3,836,600 | 3,673,600 |
| Other revenue | 606,300 | 641,600 | 617,000 |
| Total operating revenue | 60,828,600 | 61,579,200 | 60,155,600 |
| Net investment income | 801,000 | 851,100 | 1,001,100 |
| Gain on sale of business | 3,792,300 | 0 | 0 |
| Net realized gains on investments | 56,400 | 28,700 | 270,900 |
| Other-than-temporary impairment losses on investments: | |||
| Total other-than-temporary impairment losses on investments | (538,400) | (1,207,900) | (259,700) |
| Portion of other-than-temporary impairment losses recognized in other comprehensive income | 88,200 | 0 | 0 |
| Other-than-temporary impairment losses recognized in income | (450,200) | (1,207,900) | (259,700) |
| Total revenues | 65,028,100 | 61,251,100 | 61,167,900 |
| Expenses | |||
| Benefit expense | 46,571,100 | 47,742,400 | 46,037,200 |
| Selling, general and administrative expense: | |||
| Selling expense | 1,685,500 | 1,778,400 | 1,716,800 |
| General and administrative expense | 7,973,600 | 7,242,100 | 6,984,700 |
| Total selling, general and administrative expense | 9,659,100 | 9,020,500 | 8,701,500 |
| Cost of drugs | 419,000 | 468,500 | 432,700 |
| Interest expense | 447,400 | 469,800 | 447,900 |
| Amortization of other intangible assets | 266,000 | 286,100 | 290,700 |
| Impairment of goodwill and other intangible assets | 262,500 | 141,400 | 0 |
| Total expenses | 57,625,100 | 58,128,700 | 55,910,000 |
| Income before income tax expense | 7,403,000 | 3,122,400 | 5,257,900 |
| Income tax expense | 2,657,100 | 631,700 | 1,912,500 |
| Net income | 4,745,900 | 2,490,700 | 3,345,400 |
| Net income per share | |||
| Basic | 9.96 | 4.79 | 5.64 |
| Diluted | 9.88 | 4.76 | 5.56 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
ELEVANCE HEALTH, INC. | |||
Ticker: ELV Fiscal Year: 2009 | |||
Statement Of Cash Flows Indirect Investment Based Operations | |||
Period Ending Dec 31, 2009 10-K (Filed: Feb 18, 2010) | |||
| (In Thousands, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2009 | Dec 31, 2008 | Dec 31, 2007 | |
| Operating activities | |||
| Net income | $ 4,745,900 | 2,490,700 | 3,345,400 |
| Adjustments to reconcile net income to net cash provided by operating activities: | |||
| Net realized gains on investments | (56,400) | (28,700) | (270,900) |
| Other-than-temporary impairment losses recognized in income | 450,200 | 1,207,900 | 259,700 |
| Loss on disposal of assets | 16,400 | 7,200 | 11,300 |
| Gain on sale of business | (3,792,300) | 0 | 0 |
| Deferred income taxes | 61,300 | (481,400) | (105,500) |
| Amortization, net of accretion | 446,400 | 466,300 | 466,000 |
| Depreciation expense | 107,100 | 105,400 | 120,200 |
| Impairment of goodwill and other intangible assets | 262,500 | 141,400 | 0 |
| Share-based compensation | 153,600 | 156,000 | 177,100 |
| Excess tax benefits from share-based compensation | (9,600) | (16,000) | (153,300) |
| Changes in operating assets and liabilities, net of effect of business combinations and divestitures: | |||
| Receivables, net | (484,200) | (558,700) | (448,600) |
| Other invested assets, current | (62,500) | 103,300 | (3,000) |
| Other assets | (119,300) | (340,200) | 174,400 |
| Policy liabilities | (748,200) | 194,900 | 257,700 |
| Unearned income | (27,300) | (26,700) | 125,500 |
| Accounts payable and accrued expenses | 952,800 | (106,300) | (235,200) |
| Other liabilities | (248,800) | (797,000) | 176,500 |
| Income taxes | 1,391,400 | (47,300) | 447,300 |
| Other, net | (100) | 64,600 | 0 |
| Net cash provided by operating activities | 3,038,900 | 2,535,400 | 4,344,600 |
| Investing activities | |||
| Purchases of fixed maturity securities | (7,186,800) | (5,691,200) | (8,512,000) |
| Proceeds from fixed maturity securities: | |||
| Sales | 4,096,600 | 5,194,900 | 6,709,000 |
| Maturities, calls and redemptions | 1,551,700 | 1,669,600 | 1,618,400 |
| Purchases of equity securities | (318,900) | (1,327,500) | (1,389,200) |
| Proceeds from sales of equity securities | 577,300 | 1,083,100 | 1,411,700 |
| Purchases of other invested assets | (49,000) | (145,000) | (102,400) |
| Proceeds from sales of other invested assets | 3,500 | 32,800 | 10,400 |
| Changes in securities lending collateral | 132,400 | 325,100 | 50,600 |
| Purchases of subsidiaries, net of cash acquired | (66,300) | (197,700) | (298,500) |
| Proceeds from sales of subsidiaries, net of cash sold | 4,672,300 | 5,000 | 0 |
| Purchases of property and equipment | (378,400) | (345,600) | (322,000) |
| Proceeds from sale of property and equipment | 400 | 12,700 | 57,300 |
| Other, net | (32,000) | 0 | (2,200) |
| Net cash provided by (used in) investing activities | 3,002,800 | 616,200 | (768,900) |
| Financing activities | |||
| Net (repayments of) proceeds from commercial paper borrowings | (397,000) | (900,600) | 502,800 |
| Proceeds from long-term borrowings | 990,300 | 525,000 | 1,978,300 |
| Net (repayments of) proceeds from short-term borrowings | (98,000) | 98,000 | 0 |
| Repayment of long-term borrowings | (919,300) | (38,700) | (509,700) |
| Changes in securities lending payable | (132,400) | (325,100) | (50,600) |
| Changes in bank overdrafts | (344,100) | 44,800 | (117,100) |
| Repurchase and retirement of common stock | (2,638,400) | (3,276,200) | (6,151,400) |
| Proceeds from exercise of employee stock options and employee stock purchase plan | 126,500 | 121,200 | 784,500 |
| Excess tax benefits from share-based compensation | 9,600 | 16,000 | 153,300 |
| Net cash used in financing activities | (3,402,800) | (3,735,600) | (3,409,900) |
| Effect of foreign exchange rates on cash and cash equivalents | (6,700) | 0 | 0 |
| Change in cash and cash equivalents | 2,632,200 | (584,000) | 165,800 |
| Cash and cash equivalents at beginning of year | 2,183,900 | 2,767,900 | |
| Cash and cash equivalents at end of year | 4,816,100 | 2,183,900 | 2,767,900 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
ELEVANCE HEALTH, INC. | ||
Ticker: ELV Fiscal Year: 2009 | ||
Statement Of Financial Position Classified | ||
Period Ending Dec 31, 2009 10-K (Filed: Feb 18, 2010) | ||
| (In Thousands, except shares in actual) | ||
| As of | As of | |
| Dec 31, 2009 | Dec 31, 2008 | |
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $ 4,816,100 | 2,183,900 |
| Investments available-for-sale, at fair value: | ||
| Fixed maturity securities (amortized cost of $15,203.1 and $1,538.6) | 15,696,900 | 1,564,800 |
| Equity securities (cost of $799.1 and $1,293.0) | 1,010,700 | 1,088,000 |
| Other invested assets, current | 26,500 | 23,600 |
| Accrued investment income | 172,800 | 172,800 |
| Premium and self-funded receivables | 3,281,000 | 3,042,900 |
| Other receivables | 879,500 | 1,373,900 |
| Income tax receivable | 0 | 159,900 |
| Securities lending collateral | 394,800 | 529,000 |
| Deferred tax assets, net | 523,800 | 779,000 |
| Other current assets | 1,268,600 | 1,212,200 |
| Total current assets | 28,070,700 | 12,130,000 |
| Long-term investments available-for-sale, at fair value: | ||
| Fixed maturity securities (amortized cost of $223.0 and $12,401.3) | 230,400 | 11,808,400 |
| Equity securities (cost of $33.4 and $34.7) | 32,500 | 30,700 |
| Other invested assets, long-term | 775,300 | 703,200 |
| Property and equipment, net | 1,099,600 | 1,054,500 |
| Goodwill | 13,264,600 | 13,461,300 |
| Other intangible assets | 8,259,300 | 8,827,200 |
| Other noncurrent assets | 393,000 | 387,900 |
| Total assets | 52,125,400 | 48,403,200 |
| Liabilities and shareholders' equity | ||
| Liabilities | ||
| Current liabilities: | ||
| Policy liabilities: | ||
| Medical claims payable | 5,450,500 | 6,184,700 |
| Reserves for future policy benefits | 62,600 | 64,500 |
| Other policyholder liabilities | 1,617,600 | 1,626,800 |
| Total policy liabilities | 7,130,700 | 7,876,000 |
| Unearned income | 1,050,000 | 1,087,700 |
| Accounts payable and accrued expenses | 2,994,100 | 2,856,500 |
| Income tax payable | 1,228,700 | 0 |
| Security trades pending payable | 37,600 | 5,800 |
| Securities lending payable | 396,600 | 529,000 |
| Short-term borrowings | 0 | 98,000 |
| Current portion of long-term debt | 60,800 | 909,700 |
| Other current liabilities | 1,775,200 | 1,657,600 |
| Total current liabilities | 14,673,700 | 15,020,300 |
| Long-term debt, less current portion | 8,338,300 | 7,833,900 |
| Reserves for future policy benefits, noncurrent | 664,600 | 664,700 |
| Deferred tax liabilities, net | 2,470,400 | 2,098,900 |
| Other noncurrent liabilities | 1,115,100 | 1,353,700 |
| Total liabilities | 27,262,100 | 26,971,500 |
| Commitments and contingencies-Note 13 | ||
| Shareholders' equity | ||
| Preferred stock, without par value, shares authorized-100,000,000; shares issued and outstanding-none | 0 | 0 |
| Common stock, par value $0.01, shares authorized-900,000,000; shares issued and outstanding: 449,789,672 and 503,230,575 | 4,500 | 5,000 |
| Additional paid-in capital | 15,192,200 | 16,843,000 |
| Retained earnings | 9,598,500 | 5,479,400 |
| Accumulated other comprehensive income (loss) | 68,100 | (895,700) |
| Total shareholders' equity | 24,863,300 | 21,431,700 |
| Total liabilities and shareholders' equity | 52,125,400 | 48,403,200 |
| External Links | |
| ELEVANCE HEALTH, INC. (ELV) Fiscal Year 2009 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |